1 asset in Melanocytic Neoplasm
Therapeutic assets addressing Melanocytic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Fludeoxyglucose Melanocytic Neoplasm | Children's Oncology Group | N/A | D (30) |